Risk Stratification Score
Risk Stratification Score - Related Videos
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
0 Views •
Cited by 40 •
2014
The NICU Network Neurobehavioral Scale (NNNS) was developed as an assessment for the at-risk infant. The purpose of this article is to describe the NNNS, provide video examples of the NNNS procedures and discuss the ways in which the exam has been used.
09:36
Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
0 Views •
Cited by 61 •
2010
Our protocol describes how to dissect the rat abdominal mammary gland and how to prepare mammary gland whole mounts. It also describes how to analyze mammary gland morphology using three end-points (number of terminal end buds, epithelial elongation and differentiation) and to use these results to predict mammary cancer risk in rats which were exposed to dietary modifications in utero or during prepuberty.
01:06
Introduction to z Scores
0 Views •
2023
A z score (or standardized value) is measured in units of the standard deviation. It tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a zero z score. It is important to note that the mean of the z scores is zero, and the standard deviation is one. z scores help...
01:17
z Scores and Area Under the Curve
0 Views •
2023
z scores are the standardized values obtained after converting a normal distribution into a standard normal distribution. A z score is measured in units of the standard deviation. The z score tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a z score of zero.
26:48
Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
0 Views •
Cited by 27 •
2007
This video demonstrates the induction and clinical scoring of an animal model of multiple sclerosis: chronic-relapsing experimental autoimmune encephalomyelitis in DA rats. The disease, induced by immunizing rats with an emulsion containing whole rat spinal cord and complete Freund's adjuvant, presents clinical signs resembling the human disease.
FAQs
Each predictor contributes according to its assigned weight, so clinical findings, demographic characteristics, imaging results, and physiological measurements do not necessarily influence the estimate equally. The calculation combines these inputs and then applies a defined rule or threshold to place a person in a risk category. This structure makes decisions more consistent than relying on unstandardized judgment alone.
Validation and calibration are essential before applying a score to a neurological population. They help establish whether the instrument performs appropriately and whether its risk estimates can be interpreted in the population and condition for which it was developed. Without that context, a numerical category may not support reliable clinical or research decisions.
Risk categories should not be treated as universally interchangeable across conditions or populations. The score gains meaning from the population and condition for which it was developed, rather than serving as a context-free label. Keeping that setting in view helps prevent researchers or clinicians from transferring categories automatically to every neurological case.
To apply a score, users assemble the specified predictors, enter or combine them according to the defined calculation, and compare the result with the relevant threshold or category boundaries. The resulting estimate can then be recorded consistently for the intended outcome, supporting structured decisions rather than an informal, case-by-case approach.
In neurological practice, these scores can inform prognosis, triage, monitoring, and treatment planning. Their role is supportive: the score organizes selected evidence into a consistent estimate for decision-making, while its interpretation remains tied to the population and condition in which it was developed. This makes the tool useful across several stages of care.
In neurological research, scores can help compare patient groups and contribute to study design. Researchers may use the resulting categories or estimates to organize participants and examine outcomes within the population and condition addressed by the score. Appropriate validation and calibration remain important, because study conclusions depend on using an instrument suited to that context.